Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darren Plant

Showing results (31-40 of 101) with videos related to

Pageof 11
Sort By:
Rheumatology (Oxford, England)|August 28, 2016
Detection of anti-drug antibodies using a bridging ELISA compared with radioimmunoassay in adalimumab-treated rheumatoid arthritis patients with random drug levelsMeghna Jani, John D Isaacs, Ann W Morgan, et al.
Annals of the Rheumatic Diseases|December 11, 2013
Testing the role of vitamin D in response to antitumour necrosis factor α therapy in a UK cohort: a Mendelian randomisation approachAnnie Yarwood, Sebastien Viatte, Darren Plant, et al.
The Lancet. Rheumatology|October 3, 2025
Synovial immunopathology in psoriatic arthritis: cellular and molecular insightsRyan Malcolm Hum, Maria Christofi, Samantha Louise Smith, et al.
Rheumatology (Oxford, England)|October 11, 2019
Differential DNA methylation correlates with response to methotrexate in rheumatoid arthritisNisha Nair, Darren Plant, Suzanne M Verstappen, et al.
SLAS Discovery : Advancing Life Sciences R & D|February 3, 2023
High throughput screening of 0.5 million compounds against CRAF using Alpha CETSA<sup>Ⓡ</sup>Hannah Rowlands, Kirsten Tschapalda, Carolyn Blackett, et al.
The Pharmacogenomics Journal|December 11, 2019
Proteomic analysis to define predictors of treatment response to adalimumab or methotrexate in rheumatoid arthritis patientsStephanie F Ling, Nisha Nair, Suzanne M M Verstappen, et al.
Arthritis Research & Therapy|December 16, 2015
Investigating CD11c expression as a potential genomic biomarker of response to TNF inhibitor biologics in whole blood rheumatoid arthritis samplesSamantha Louise Smith, Stephen Eyre, Annie Yarwood, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 31, 2025
Genome-Wide Aggregated Trans Effects Analysis Identifies Genes Encoding Immune Checkpoints as Core Genes for Rheumatoid ArthritisAthina Spiliopoulou, Andrii Iakovliev, Darren Plant, et al.
Scientific Reports|April 1, 2021
Prediction of response of methotrexate in patients with rheumatoid arthritis using serum lipidomicsMateusz Maciejewski, Caroline Sands, Nisha Nair, et al.
Rheumatology (Oxford, England)|March 12, 2010
The role of rheumatoid arthritis genetic susceptibility markers in the prediction of erosive disease in patients with early inflammatory polyarthritis: results from the Norfolk Arthritis RegisterDarren Plant, Wendy Thomson, Mark Lunt, et al.
Pageof 11

Showing results (31-40 of 101) with videos related to

Sort By:
Pageof 11
Rheumatology (Oxford, England)|August 28, 2016
Detection of anti-drug antibodies using a bridging ELISA compared with radioimmunoassay in adalimumab-treated rheumatoid arthritis patients with random drug levelsMeghna Jani, John D Isaacs, Ann W Morgan, et al.
Annals of the Rheumatic Diseases|December 11, 2013
Testing the role of vitamin D in response to antitumour necrosis factor α therapy in a UK cohort: a Mendelian randomisation approachAnnie Yarwood, Sebastien Viatte, Darren Plant, et al.
The Lancet. Rheumatology|October 3, 2025
Synovial immunopathology in psoriatic arthritis: cellular and molecular insightsRyan Malcolm Hum, Maria Christofi, Samantha Louise Smith, et al.
Rheumatology (Oxford, England)|October 11, 2019
Differential DNA methylation correlates with response to methotrexate in rheumatoid arthritisNisha Nair, Darren Plant, Suzanne M Verstappen, et al.
SLAS Discovery : Advancing Life Sciences R & D|February 3, 2023
High throughput screening of 0.5 million compounds against CRAF using Alpha CETSA<sup>Ⓡ</sup>Hannah Rowlands, Kirsten Tschapalda, Carolyn Blackett, et al.
The Pharmacogenomics Journal|December 11, 2019
Proteomic analysis to define predictors of treatment response to adalimumab or methotrexate in rheumatoid arthritis patientsStephanie F Ling, Nisha Nair, Suzanne M M Verstappen, et al.
Arthritis Research & Therapy|December 16, 2015
Investigating CD11c expression as a potential genomic biomarker of response to TNF inhibitor biologics in whole blood rheumatoid arthritis samplesSamantha Louise Smith, Stephen Eyre, Annie Yarwood, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 31, 2025
Genome-Wide Aggregated Trans Effects Analysis Identifies Genes Encoding Immune Checkpoints as Core Genes for Rheumatoid ArthritisAthina Spiliopoulou, Andrii Iakovliev, Darren Plant, et al.
Scientific Reports|April 1, 2021
Prediction of response of methotrexate in patients with rheumatoid arthritis using serum lipidomicsMateusz Maciejewski, Caroline Sands, Nisha Nair, et al.
Rheumatology (Oxford, England)|March 12, 2010
The role of rheumatoid arthritis genetic susceptibility markers in the prediction of erosive disease in patients with early inflammatory polyarthritis: results from the Norfolk Arthritis RegisterDarren Plant, Wendy Thomson, Mark Lunt, et al.
Pageof 11